Since generic-drug maker Mylan’s unsolicited $28.9 billion bid for her company in April, Perrigo CFO Judy Gawlik Brown has spent nearly six of the past seven months on the road, trying to get investors to reject its offers.
from WSJ.com: US Business http://ift.tt/1O0x2Z4
via IFTTT
No comments:
Post a Comment